|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 308,500.00 KRW | +10.38% |
|
+2.66% | -31.37% |
| 06-10 | Alteogen Inc Showcases Preclinical Data On ALT-B4-Enabled Subcutaneous ADC Formulation At World ADC Summit | CI |
| 05-08 | Alteogen's Net Income Declines 14% in Q1 | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 333,000 | 333,000 | 369,000 |
| Spread/Res. | -7.36% | -7.36% | -16.40% |
| Spread/Supp. | +15.11% | +15.11% | +11.57% |
| Support | 268,000 | 268,000 | 276,500 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A196170 Stock
- Charts ALTEOGEN Inc.
Select your edition
All financial news and data tailored to specific country editions
